Regeneron Pharmaceuticals, Inc.

DODGE & COX REGN
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
4,458,238
Value ($000)
3,444,613
Weight
1.9%
2021 Q4 - 2026 Q1 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).